Drug intelligence / Profile preview

AAV-shPank3

Development stage
Preclinical
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies
Administration
Intravenous
01

Overview

AAV-shPank3 is an experimental gene therapy vector that utilizes an adeno-associated virus (AAV) to deliver short hairpin RNA (shRNA) targeting Pantothenate Kinase 3 (PANK3). PANK3 is a key enzyme in the Coenzyme A biosynthesis pathway and has been identified as a critical component of the c-Myc-PANK3-EMT axis, which regulates the structural integrity and function of the intestinal barrier. In preclinical models of ulcerative colitis, AAV-shPank3-mediated knockdown of PANK3 has been shown to inhibit epithelial-mesenchymal transition (EMT) and promote the repair of the intestinal epithelium. This approach represents a potential therapeutic strategy for restoring barrier function and treating the underlying pathology of ulcerative colitis by modulating the c-Myc-PANK3-EMT axis.

Other names
AAV-shRNA-PANK3AAV-shRNA-PANK-3AAV-shRNA-PANK 3AAV-shPANK3AAV-shPANK-3AAV-shPANK 3
02

Targets

PANK3 (Pantothenate kinase 3)

Beyond the preview

Go deeper on AAV-shPank3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAV-shPank3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call